One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.24292/01.mf.0420.3
Copy DOI
Export
Save
Share
Cite Journal: Medycyna Faktów |  Publication Date: Dec 31, 2020 |
Most of the currently used drugs in diabetes reduce only the risk of macrovascular complications. This effects in only a small reduction of total mortality. The article describes empagliflozin – the first drug that reduces total mortality in diabetic patients with high cardiovascular risk.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
